Z-1684-2021 Class II Terminated

Recalled by Baxter Healthcare Corporation — Deerfield, IL

FDA device recall Z-1684-2021 was initiated by Baxter Healthcare Corporation on Apr 14, 2021 and is designated Class II. Reason for recall: There is a potential leak between the venous patient connector and patient's hemodialysis access. The recall status is terminated (terminated May 10, 2024). Affected quantity: 17,487 units.

Recall details

Product Type
Devices
Report Date
Jun 2, 2021
Initiation Date
Apr 14, 2021
Termination Date
May 10, 2024
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
17,487 units

Product description

Gambro Cartridge Blood Set, Product Code 101025 - Product Usage: intended for single use in a hemodialysis treatment using the Phoenix Dialysis Delivery Systems.

Reason for recall

There is a potential leak between the venous patient connector and patient's hemodialysis access.

Distribution pattern

Worldwide distribution - United States distribution and the countries of Canada, Korea, and Norway.

Code information

Product Code: 101025; Lot 1000276191, UDI: 37332414007837

Source

Dataset
openFDA device recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for Z-1684-2021
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for Z-1684-2021. Report a data issue: hello@regdatalab.com.